Standard
Quality of Life in Danish Blood Donors Treated for Superficial Fungal Infection. / Lindsø Andersen, Pernille; Jemec, Gregor B.E.; Loft, Isabella C.; Saunte, Ditte M.L.; Pedersen, Ole B.
I:
Acta Dermato-Venereologica, Bind 101, Nr. 12, adv00617, 2021.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Lindsø Andersen, P
, Jemec, GBE, Loft, IC
, Saunte, DML & Pedersen, OB 2021, '
Quality of Life in Danish Blood Donors Treated for Superficial Fungal Infection',
Acta Dermato-Venereologica, bind 101, nr. 12, adv00617.
https://doi.org/10.2340/actadv.v101.749APA
Lindsø Andersen, P.
, Jemec, G. B. E., Loft, I. C.
, Saunte, D. M. L., & Pedersen, O. B. (2021).
Quality of Life in Danish Blood Donors Treated for Superficial Fungal Infection.
Acta Dermato-Venereologica,
101(12), [adv00617].
https://doi.org/10.2340/actadv.v101.749Vancouver
Lindsø Andersen P
, Jemec GBE, Loft IC
, Saunte DML, Pedersen OB.
Quality of Life in Danish Blood Donors Treated for Superficial Fungal Infection.
Acta Dermato-Venereologica. 2021;101(12). adv00617.
https://doi.org/10.2340/actadv.v101.749Author
Lindsø Andersen, Pernille ; Jemec, Gregor B.E. ; Loft, Isabella C. ; Saunte, Ditte M.L. ; Pedersen, Ole B. / Quality of Life in Danish Blood Donors Treated for Superficial Fungal Infection. I: Acta Dermato-Venereologica. 2021 ; Bind 101, Nr. 12.
Bibtex
@article{83e42be1fe1f4575aa5174ac65f25a24,
title = "Quality of Life in Danish Blood Donors Treated for Superficial Fungal Infection",
author = "{Linds{\o} Andersen}, Pernille and Jemec, {Gregor B.E.} and Loft, {Isabella C.} and Saunte, {Ditte M.L.} and Pedersen, {Ole B.}",
note = "Funding Information: PLA and ICL received support from Naestved, Slagelse and Ringsted Hospitals{\textquoteright}Research Fund, and PLAreceived a PhD grant Funding Information: The Danish Blood Donor Study is funded by: The Danish Coun-cil for Independent Research ? Medical Sciences (grant number 09-069412); The Danish Administrative Regions (http://www. regioner.dk); The A. P. M?ller Foundation for the Advancement of Medical Science; The Danish Bio-and Genome Bank (http:// www.regioner.dk/rbgben). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of this manuscript. Oral and written informed consent was obtained from all participants. The DBDS (1-10-72-95-13) and DBDSII (SJ-740) are approved by the Scientific Ethical Committees in Central Denmark Region and Region Zealand, respectively. The DBDS was approved by the Danish Data Protection Agency (P-2019-99). This study was conducted in accordance with the principles of the Declaration of Helsinki. PLA and ICL received support from Naestved, Slagelse and Ringsted Hospitals? Research Fund, and PLA received a PhD grant from LEO Foundation (grant number LF18002). DMLS participated in advisory board meeting by AbbVie, Janssen, Sanofi, Leo Pharma and received honoraria. DMLS also received speaker?s honoraria and/or grants from the following companies: Abbvie, Desitin, Pfizer, Galderma, Novartis and Leo Pharma during the last 5 years. GBJ reports grants from Leo Research Foundation, during the conduct of the study; personal fees from Abbvie, personal fees from Chemocentryx, personal fees from Kymera, personal fees from Leo Pharma, personal fees from Coloplast, grants and personal fees from Novartis, grants and personal fees from UCB, grants and personal fees from Inflarx, grants from Janssen-Cilag, grants from Serono, grants from Regeneron, outside the submitted work. OBP has no conflicts of interests to disclose. Funding Information: The Danish Blood Donor Study is funded by: The Danish Council for Independent Research – Medical Sciences (grant number 09-069412); The Danish Administrative Regions (http://www. regioner.dk); The A. P. M{\o}ller Foundation for the Advancement of Medical Science; The Danish Bio-and Genome Bank (http:// www.regioner.dk/rbgben). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of this manuscript.",
year = "2021",
doi = "10.2340/actadv.v101.749",
language = "English",
volume = "101",
journal = "Acta Dermato-Venereologica",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato - Venereologica",
number = "12",
}
RIS
TY - JOUR
T1 - Quality of Life in Danish Blood Donors Treated for Superficial Fungal Infection
AU - Lindsø Andersen, Pernille
AU - Jemec, Gregor B.E.
AU - Loft, Isabella C.
AU - Saunte, Ditte M.L.
AU - Pedersen, Ole B.
N1 - Funding Information:
PLA and ICL received support from Naestved, Slagelse and Ringsted Hospitals’Research Fund, and PLAreceived a PhD grant
Funding Information:
The Danish Blood Donor Study is funded by: The Danish Coun-cil for Independent Research ? Medical Sciences (grant number 09-069412); The Danish Administrative Regions (http://www. regioner.dk); The A. P. M?ller Foundation for the Advancement of Medical Science; The Danish Bio-and Genome Bank (http:// www.regioner.dk/rbgben). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of this manuscript. Oral and written informed consent was obtained from all participants. The DBDS (1-10-72-95-13) and DBDSII (SJ-740) are approved by the Scientific Ethical Committees in Central Denmark Region and Region Zealand, respectively. The DBDS was approved by the Danish Data Protection Agency (P-2019-99). This study was conducted in accordance with the principles of the Declaration of Helsinki. PLA and ICL received support from Naestved, Slagelse and Ringsted Hospitals? Research Fund, and PLA received a PhD grant from LEO Foundation (grant number LF18002). DMLS participated in advisory board meeting by AbbVie, Janssen, Sanofi, Leo Pharma and received honoraria. DMLS also received speaker?s honoraria and/or grants from the following companies: Abbvie, Desitin, Pfizer, Galderma, Novartis and Leo Pharma during the last 5 years. GBJ reports grants from Leo Research Foundation, during the conduct of the study; personal fees from Abbvie, personal fees from Chemocentryx, personal fees from Kymera, personal fees from Leo Pharma, personal fees from Coloplast, grants and personal fees from Novartis, grants and personal fees from UCB, grants and personal fees from Inflarx, grants from Janssen-Cilag, grants from Serono, grants from Regeneron, outside the submitted work. OBP has no conflicts of interests to disclose.
Funding Information:
The Danish Blood Donor Study is funded by: The Danish Council for Independent Research – Medical Sciences (grant number 09-069412); The Danish Administrative Regions (http://www. regioner.dk); The A. P. Møller Foundation for the Advancement of Medical Science; The Danish Bio-and Genome Bank (http:// www.regioner.dk/rbgben). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of this manuscript.
PY - 2021
Y1 - 2021
U2 - 10.2340/actadv.v101.749
DO - 10.2340/actadv.v101.749
M3 - Journal article
C2 - 34842934
AN - SCOPUS:85122771281
VL - 101
JO - Acta Dermato-Venereologica
JF - Acta Dermato-Venereologica
SN - 0001-5555
IS - 12
M1 - adv00617
ER -
